Healthcare

Shares of Telix Pharmaceuticals Ltd (ASX:TLX) tumbled on Monday after the company announced that the U.S. Food and Drug Administration (FDA) had rejected its new drug application (NDA) for Pixclara, an experimental imaging agent designed for detecting glioma.

San Diego-based ResMed Inc. (NYSE:RMD) topped Wall Street’s expectations for third-quarter earnings, driven by continued demand for its sleep apnea treatment devices. The company reported an adjusted profit of $2.37 per share for the quarter ended March 31, edging past analysts’ consensus estimate of …

A new report from Macquarie has identified three healthcare companies listed on the ASX that could present potential opportunities based on recent developments and forecasted changes in the sector. The companies include Regis Healthcare Ltd (ASX: REG), Integral Diagnostics Ltd (ASX: IDX), and Summerset …

Pro Medicus Ltd (ASX: PME) shares saw a slight increase to AU$213.50 on Tuesday following the announcement of a multi-year research collaboration with the University of California, San Francisco (UCSF). The health imaging technology company entered into the agreement to advance artificial intelligence (AI) …

Health tech firm Visionflex Group (ASX:VFX) has inked a strategic AU$1 million partnership with Amplar Home Health, the care delivery arm of Medibank, to bring virtual nursing services and personalised clinical care to aged care homes across Australia.

Shares of Neuren Pharmaceuticals Ltd (ASX:NEU) surged 18% to AU$10.83 in morning trade, marking one of the biotech sector's performances to kick off the week. The sharp rally follows a significant regulatory milestone that could bring the company closer to launching a world-first treatment …

Argenica Therapeutics Limited (ASX:AGN), a clinical-stage biotechnology company developing neuroprotective therapeutics, has successfully completed dosing of all patients in its Phase 2 clinical trial evaluating ARG-007 in patients with acute ischaemic stroke (AIS).